Stephen W. Waldo et al. JACC 2008;51:

Slides:

Advertisements

Similar presentations

Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure Fonarow GC et al. J Am Coll Cardiol 2007; 49(19):

Advertisements

Mahmoud Farhoud, MD 1,2, Paul Ndunda, MD 2,K James Kallail, PhD 2, Hussam Farhoud, MD, FACC 3 1 University of Central Florida College of Medicine, 2 University.

Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Utility of B-type natriuretic peptide in the diagnosis.

Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: N-terminal pro brain natriuretic peptide on admission.

Volume 69, Issue 2, Pages (February 2017)

The Association of Five-Year Changes in the Levels of N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP) with Subsequent.

Muhammad Shahreyar et al. JACEP 2016;j.jacep

Median NT-proBNP levels (pg/mL) by GFR and 60-day survival

Diabetes Mellitus and Heart Failure

Clyde W. Yancy et al. JACC 2017;70:

Robert W. Yeh et al. JACC 2017;70:

Relationship between perioperative N-terminal pro-brain natriuretic peptide and maximum inotropic score in children after cardiac surgery Yanqin Cui,

Biomarker-Guided HF Therapy: Is It Cost-Effective?

Stavros V. Konstantinides et al. JACC 2016;67:

Dean J. Kereiakes et al. JACC 2017;70:

Orly Vardeny et al. JCHF 2014;2:

G. Michael Felker et al. JCHF 2014;2:

Kenshi Hayashi et al. JACEP 2016;2:

Brian P. Shapiro, MD, Horng H. Chen, MD, John C

Editorial Heart Failure Clinics

N-terminal pro B-type natriuretic peptide is an independent predictor of postoperative myocardial injury in patients undergoing major vascular surgery

N-terminal fragment of pro-B-type natriuretic peptide is a predictor of cardiac events in high-risk patients undergoing acute hip fracture surgery A.

Overcoming Clinical Inertia

Hospital-level variation in diagnostic testing for children with AGE evaluated in the ED and discharged from (A) or admitted to (B) the hospital. Hospital-level.

Belinda Gray et al. JCHF 2013;1:

High concentrations of N-BNP are related to non-infectious severe SIRS associated with cardiovascular dysfunction occurring after off-pump coronary artery.

Muhammad Shahreyar et al. JACEP 2016;j.jacep

Serum levels of angiopoietin-like protein 4 according to (A) cardiac dysfunction (ie, abnormal N-terminal pro-B-type natriuretic peptide level) and (B)

Volume 8, Issue 2, Pages (February 2011)

Late remote ischemic preconditioning in children undergoing cardiopulmonary bypass: A randomized controlled trial Marcos A. Pavione, MD, Fabio Carmona,

Correlation of E/e’ with age (A), gender (B), fasting insulin (C), and sulfonylurea use (SU) (D) among patients with type 2 diabetes mellitus. Correlation.

K.R. Julian Chun et al. JACEP 2017;3:

Svend A. Mortensen et al. JCHF 2014;2:

Yoshitaka Kimura et al. JACEP 2016;2:

Kenshi Hayashi et al. JACEP 2016;2:

P. Michael Grossman et al. JCIN 2009;2:

Peter E. Carson et al. JCHF 2015;3:

Risk assessment and treat-to-target approach for pulmonary arterial hypertension. Risk assessment and treat-to-target approach for pulmonary arterial hypertension.

Box- and whisker plots demonstrating the distribution of 300 μm manual trace corneal nerve fiber length (CNFL) in 39 type 1 diabetic participants. Box-

Jennifer T. Thibodeau et al. JCHF 2014;2:24-31

Thirty-day survival curves for the rapid versus slow correction rate groups are not significantly different. Thirty-day survival curves for the rapid versus.

Receiver operating characteristics curve of N-terminal pro-atrial natriuretic peptide plasma levels (dark line) and brain natriuretic peptide (dashed line)

Algorithm for the outpatient management of pulmonary embolism (PE)

Chronic effect of 28-day oral administration of vehicle (n = 6–10/group) or aprocitentan 1, 10, and 100 mg/kg per day (n = 6–9/group) on mean arterial.

EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery.

Maria Rosa Costanzo et al. JCHF 2016;4:95-105

Paul M. McKie, BS, John C. Burnett, MD Mayo Clinic Proceedings

When we compared cardiac volumes (ED and ES) between those with high BNP levels (BNP >400 pg/mL) and low BNP (

Jeffrey L. Anderson et al. JACC 2007;50:e1-e157

Glenn N. Levine et al. JACC 2011;58:e44-e122

Svend A. Mortensen et al. JCHF 2014;2:

Valeria Calvi et al. JACEP 2017;j.jacep

N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels for patients undergoing surgical aortic valve replacement (SAVR) (A), patients undergoing.

Ingrid Kindermann et al. JACC 2012;59:

Fig. 3 Liver stiffness and NT-proBNP concentration after treatment with miridesap followed by dezamizumab. Liver stiffness and NT-proBNP concentration.

Steven R. Steinhubl, and Eric J. Topol JACC 2015;66:

Ryan R. Reeves et al. JCIN 2015;8:

Results of classification and regression tree analysis in patients with pulmonary hypertension-sickle cell disease. Results of classification and regression.

The possible off-target effect of increased heart failure hospitalizations from saxagliptin in the SAVOR trial. The possible off-target effect of increased.

Figure 1 Novel markers of increased stroke risk in AF

Zeenat Safdar et al. JCHF 2014;2:

Jeffrey Senfield et al. JACEP 2017;3:

Writing Committee Members et al. JACC 2018;j.jacc

Orly Vardeny et al. JCHF 2016;4:

Associations of peripartum biomarker levels with e' at 1 month postpartum (PP2). Associations of peripartum biomarker levels with e' at 1 month postpartum.

Analysis of receiver operating characteristic of three models (model 1: cardiac troponin T (cTnT), N-terminal pro brain natriuretic peptide (NT-proBNP),

Spearman’s rank correlation between preoperative serum levels of BNP/NT-proBNP and expression of HIF-2 alpha and preoperative serum level of VEGF. There.

Changes in the plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) level from baseline to treatment titration and 3 months of therapy: full analysis.

Flow diagram of the recommended pharmacological management of heart failure adapted from the European Society of Cardiology guidelines Flow diagram.

Overall survival in all cases.

Presentation transcript:

Stephen W. Waldo et al. JACC 2008;51:1874-1882 Natriuretic Peptides and Cardiac Death Admission and discharge plasma natriuretic peptide levels were evaluated in patients that met the primary end point. The box and whisker plots in A demonstrate that patients that suffered a cardiac death (gray boxes) had significantly higher plasma natriuretic peptide levels at admission compared with those that did not have an event (open boxes) within 90 days of hospital discharge. Panel B demonstrates that B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptides (NT-proBNP) levels were also significantly elevated at discharge in patients suffering a cardiac death (gray boxes) when compared with those that did not (open boxes). Stephen W. Waldo et al. JACC 2008;51:1874-1882 American College of Cardiology Foundation